NCT01096017View on ClinicalTrials.gov

To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Asthma
Interventions
DRUG

Terbutaline Turbuhaler®

0.4 mg, inhalation, single dose

DRUG

Salbutamol pMDI

200 μg, inhalation, single dose

OTHER

pMDI placebo pMDI

Placebo pMDI 2 inhalations

OTHER

Placebo Turbuhaler®

Placebo Turbuhaler 1 inhalation

Trial Locations (1)

Unknown

Research Site, Tokyo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY